Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic cardiomyopathy
- PMID: 37847855
- DOI: 10.1093/eurheartj/ehad686
Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic cardiomyopathy
Comment in
-
Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.Eur Heart J. 2023 Dec 1;44(45):4781-4792. doi: 10.1093/eurheartj/ehad581. Eur Heart J. 2023. PMID: 37795986
Comment on
-
Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.Eur Heart J. 2023 Dec 1;44(45):4781-4792. doi: 10.1093/eurheartj/ehad581. Eur Heart J. 2023. PMID: 37795986
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
